home / stock / shpg / shpg quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $179.20 |
High: | $N/A |
Low: | $N/A |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $179.20 | $N/A | $N/A | 1 | 01-07-2019 |
$ | $176.60 | $179.20 | $181.22 | $175.71 | 5,316,930 | 01-04-2019 |
$ | $172.38 | $172.15 | $173.30 | $171.48 | 1,746,076 | 01-03-2019 |
$ | $173.00 | $172.70 | $173.67 | $171.57 | 1,152,604 | 01-02-2019 |
$ | $173.63 | $174.04 | $174.50 | $173.33 | 699,244 | 12-31-2018 |
$ | $173.94 | $173.00 | $173.94 | $172.415 | 1,001,350 | 12-28-2018 |
$ | $172.70 | $173.98 | $174.04 | $171.27 | 712,793 | 12-27-2018 |
$ | $171.55 | $174.90 | $174.99 | $171.30 | 984,950 | 12-26-2018 |
$ | $169.16 | $169.07 | $170.19 | $168.78 | 813,146 | 12-24-2018 |
$ | $169.79 | $170.03 | $172.07 | $168.74 | 6,966,841 | 12-21-2018 |
$ | $171.94 | $171.21 | $172.46 | $170.05 | 3,706,414 | 12-20-2018 |
$ | $168.24 | $168.73 | $169.18 | $167.46 | 2,556,492 | 12-19-2018 |
$ | $166.92 | $166.22 | $167.205 | $165.29 | 4,112,660 | 12-18-2018 |
$ | $171.95 | $170.08 | $172.34 | $168.75 | 3,750,665 | 12-17-2018 |
$ | $175.33 | $174.95 | $176.56 | $174.73 | 2,106,675 | 12-14-2018 |
$ | $175.34 | $176.69 | $176.79 | $174.95 | 2,274,136 | 12-13-2018 |
$ | $171.85 | $172.48 | $173.12 | $171.60 | 1,981,511 | 12-12-2018 |
$ | $170.05 | $169.66 | $170.70 | $168.92 | 2,096,796 | 12-11-2018 |
$ | $170.545 | $170.12 | $171.1375 | $168.66 | 2,263,577 | 12-10-2018 |
$ | $174.04 | $172.75 | $174.93 | $171.99 | 2,262,664 | 12-07-2018 |
News, Short Squeeze, Breakout and More Instantly...
Shire plc Company Name:
SHPG Stock Symbol:
NASDAQ Market:
After updating investors earlier this week on the timeline for filing a new drug application for its lead drug candidate, maralixibat, in Alagille syndrome (ALGS), Mirum Pharmaceuticals (NASDAQ:MIRM) saw its shares rally 44.1% on Wednesday. Mirum is a relatively new company ded...
As the US Department of Health and Human Services notes, Alzheimer’s disease (AD) is a degenerative brain disorder that results in cognitive decline and basic thinking skills which slowly gets worse over time. According to a 2019 Alzheimer’s disease facts and figures re...